These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35586748)

  • 41. Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: a 9-year follow-up study.
    Cannone V; Huntley BK; Olson TM; Heublein DM; Scott CG; Bailey KR; Redfield MM; Rodeheffer RJ; Burnett JC
    Hypertension; 2013 Nov; 62(5):860-5. PubMed ID: 24041948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic Dissection of a Super Enhancer Controlling the
    Man JCK; van Duijvenboden K; Krijger PHL; Hooijkaas IB; van der Made I; de Gier-de Vries C; Wakker V; Creemers EE; de Laat W; Boukens BJ; Christoffels VM
    Circ Res; 2021 Jan; 128(1):115-129. PubMed ID: 33107387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy.
    Bégué C; Mörner S; Brito D; Hengstenberg C; Cleland JGF; Arbustini E; Galve E; Wichter T; Richter A; Golmard JL; Bernard M; Dubourg O; Komajda M; Charron P; Isnard R
    Heart; 2020 Feb; 106(3):196-202. PubMed ID: 31350276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression and regulation of the atrial natriuretic factor encoding gene Nppa during development and disease.
    Houweling AC; van Borren MM; Moorman AF; Christoffels VM
    Cardiovasc Res; 2005 Sep; 67(4):583-93. PubMed ID: 16002056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure.
    Newton-Cheh C; Larson MG; Vasan RS; Levy D; Bloch KD; Surti A; Guiducci C; Kathiresan S; Benjamin EJ; Struck J; Morgenthaler NG; Bergmann A; Blankenberg S; Kee F; Nilsson P; Yin X; Peltonen L; Vartiainen E; Salomaa V; Hirschhorn JN; Melander O; Wang TJ
    Nat Genet; 2009 Mar; 41(3):348-53. PubMed ID: 19219041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serial Assessment of Natriuretic Peptides in Patients Undergoing Interventional Closure of the Left Atrial Appendage.
    Luani B; Rauwolf T; Groscheck T; Tanev I; Herold J; Isermann B; Schmeisser A; Braun-Dullaeus RC
    Heart Lung Circ; 2018 Jul; 27(7):828-834. PubMed ID: 28818408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biomarkers of microvascular endothelial dysfunction predict incident dementia: a population-based prospective study.
    Holm H; Nägga K; Nilsson ED; Ricci F; Melander O; Hansson O; Bachus E; Magnusson M; Fedorowski A
    J Intern Med; 2017 Jul; 282(1):94-101. PubMed ID: 28407377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RNA sequencing analysis and atrial natriuretic peptide production in patients with dilated and ischemic cardiomyopathy.
    Tarazón E; Roselló-Lletí E; Rivera M; Ortega A; Molina-Navarro MM; Triviño JC; Lago F; González-Juanatey JR; Orosa P; Montero JA; Salvador A; Portolés M
    PLoS One; 2014; 9(3):e90157. PubMed ID: 24599027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke.
    Schweizer J; Arnold M; König IR; Bicvic A; Westphal LP; Schütz V; Inauen C; Scherrer N; Luft A; Galovic M; Ferreira Atuesta C; Pokorny T; Arnold M; Fischer U; Bonati LH; De Marchis GM; Kahles T; Nedeltchev K; Cereda CW; Kägi G; Bustamante A; Montaner J; Ntaios G; Sagris D; Foerch C; Spanaus K; von Eckardstein A; Katan M
    J Am Coll Cardiol; 2022 Apr; 79(14):1369-1381. PubMed ID: 35393018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gestational hypertension in atrial natriuretic peptide knockout mice and the developmental origins of salt-sensitivity and cardiac hypertrophy.
    Armstrong DW; Tse MY; O'Tierney-Ginn PF; Wong PG; Ventura NM; Janzen-Pang JJ; Matangi MF; Johri AM; Croy BA; Adams MA; Pang SC
    Regul Pept; 2013 Sep; 186():108-15. PubMed ID: 23981445
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mid-regional pro-atrial natriuretic peptide levels before and after hemodialysis predict long-term prognosis.
    Hasselbalch RB; Kristensen JH; Nielsen TL; Plesner LL; Rydahl C; Schou M; Goetze JP; Bundgaard H; Iversen KK
    Clin Biochem; 2021 Aug; 94():20-26. PubMed ID: 33865815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mid-regional pro-atrial natriuretic peptide levels in the elderly: clinical and prognostic implications, and comparison to B-type natriuretic peptides.
    Eggers KM; Venge P; Lind L
    Clin Chim Acta; 2013 Apr; 419():62-6. PubMed ID: 23415698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction.
    Jensen J; Schou M; Kistorp C; Faber J; Hansen TW; Jensen MT; Andersen HU; Rossing P; Vilsbøll T; Jørgensen PG
    Cardiovasc Diabetol; 2020 Oct; 19(1):180. PubMed ID: 33066783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma N-terminal fragments of natriuretic propeptides predict the risk of cardiovascular events and mortality in middle-aged men.
    Laukkanen JA; Kurl S; Ala-Kopsala M; Vuolteenaho O; Ruskoaho H; Nyyssönen K; Salonen JT
    Eur Heart J; 2006 May; 27(10):1230-7. PubMed ID: 16621869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epigenetic regulation and gene expression of vasopressin and atrial natriuretic peptide in alcohol withdrawal.
    Hillemacher T; Frieling H; Luber K; Yazici A; Muschler MA; Lenz B; Wilhelm J; Kornhuber J; Bleich S
    Psychoneuroendocrinology; 2009 May; 34(4):555-60. PubMed ID: 19046820
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered expression of natriuretic peptide receptors in proANP gene disrupted mice.
    Vera N; Tse MY; Watson JD; Sarda S; Steinhelper ME; John SW; Flynn TG; Pang SC
    Cardiovasc Res; 2000 Jun; 46(3):595-603. PubMed ID: 10912470
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electrophysiologic and molecular mechanisms of a frameshift NPPA mutation linked with familial atrial fibrillation.
    Menon A; Hong L; Savio-Galimberti E; Sridhar A; Youn SW; Zhang M; Kor K; Blair M; Kupershmidt S; Darbar D
    J Mol Cell Cardiol; 2019 Jul; 132():24-35. PubMed ID: 31077706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A review of the role of atrial natriuretic peptide gene polymorphisms in hypertension and its sequelae.
    Lynch AI; Claas SA; Arnett DK
    Curr Hypertens Rep; 2009 Feb; 11(1):35-42. PubMed ID: 19146799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antisense regulation of atrial natriuretic peptide expression.
    Celik S; Sadegh MK; Morley M; Roselli C; Ellinor PT; Cappola T; Smith JG; Gidlöf O
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31503546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy.
    Arrigo M; Truong QA; Szymonifka J; Rivas-Lasarte M; Tolppanen H; Sadoune M; Gayat E; Cohen-Solal A; Ruschitzka F; Januzzi JL; Singh JP; Mebazaa A
    Europace; 2017 Nov; 19(11):1848-1854. PubMed ID: 28096288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.